Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Damage control surgery for unstable thoracic wall injury.

Shimojo Y, Kuramoto S, Muronoi T, Oka K, Kidani A, Hira E, Watanabe H.

Trauma Case Rep. 2019 Apr 6;21:100188. doi: 10.1016/j.tcr.2019.100188. eCollection 2019 Jun.

2.

Mediastinal, retroperitoneal, and subcutaneous emphysema due to sigmoid colon penetration: A case report and literature review.

Muronoi T, Kidani A, Hira E, Takeda K, Kuramoto S, Oka K, Shimojo Y, Watanabe H.

Int J Surg Case Rep. 2019;55:213-217. doi: 10.1016/j.ijscr.2019.02.003. Epub 2019 Feb 10.

3.

First establishment of a new table-rotated-type hybrid emergency room system.

Watanabe H, Shimojo Y, Hira E, Kuramoto S, Muronoi T, Oka K, Kidani A.

Scand J Trauma Resusc Emerg Med. 2018 Sep 17;26(1):80. doi: 10.1186/s13049-018-0532-z. Review.

4.

A Novel Prognostic Scoring System Using Inflammatory Response Biomarkers for Esophageal Squamous Cell Carcinoma.

Hirahara N, Tajima Y, Fujii Y, Yamamoto T, Hyakudomi R, Hirayama T, Taniura T, Ishitobi K, Kidani A, Kawabata Y.

World J Surg. 2018 Jan;42(1):172-184. doi: 10.1007/s00268-017-4144-y.

6.

Superior mesenteric artery-first approach in radical antegrade modular pancreatosplenectomy for borderline resectable pancreatic cancer: a technique to obtain negative tangential margins.

Kawabata Y, Hayashi H, Takai K, Kidani A, Tajima Y.

J Am Coll Surg. 2015 May;220(5):e49-54. doi: 10.1016/j.jamcollsurg.2014.12.054. Epub 2015 Jan 26. No abstract available.

PMID:
25840548
7.

A novel technique to minimize deformation of the stomach in laparoscopic partial gastrectomy for intraluminal gastric GISTs.

Hirahara N, Matsubara T, Kidani A, Hyakudomi R, Fujii Y, Tajima Y.

J Laparoendosc Adv Surg Tech A. 2014 Oct;24(10):707-11. doi: 10.1089/lap.2014.0184. Epub 2014 Sep 2.

PMID:
25181572
8.

Safe and simple gastric conduit pull-through procedure through the posterior mediastinal route using echo probe cover in thoracoscopic subtotal esophagectomy.

Hirahara N, Matsubara T, Hira E, Yamamoto T, Kidani A, Hyakudomi R, Shimojo Y, Tajima Y.

Surg Laparosc Endosc Percutan Tech. 2013 Aug;23(4):e141-4. doi: 10.1097/SLE.0b013e31828b81a7.

PMID:
23917601
9.

Circadian disruption accelerates tumor growth and angio/stromagenesis through a Wnt signaling pathway.

Yasuniwa Y, Izumi H, Wang KY, Shimajiri S, Sasaguri Y, Kawai K, Kasai H, Shimada T, Miyake K, Kashiwagi E, Hirano G, Kidani A, Akiyama M, Han B, Wu Y, Ieiri I, Higuchi S, Kohno K.

PLoS One. 2010 Dec 23;5(12):e15330. doi: 10.1371/journal.pone.0015330.

10.

Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines.

Kashiwagi E, Izumi H, Yasuniwa Y, Baba R, Doi Y, Kidani A, Arao T, Nishio K, Naito S, Kohno K.

Cancer Sci. 2011 Feb;102(2):382-6. doi: 10.1111/j.1349-7006.2010.01784.x. Epub 2010 Nov 19.

11.

Enhanced expression of PCAF endows apoptosis resistance in cisplatin-resistant cells.

Hirano G, Izumi H, Kidani A, Yasuniwa Y, Han B, Kusaba H, Akashi K, Kuwano M, Kohno K.

Mol Cancer Res. 2010 Jun;8(6):864-72. doi: 10.1158/1541-7786.MCR-09-0458. Epub 2010 Jun 8.

12.

Thioredoxin2 enhances the damaged DNA binding activity of mtTFA through direct interaction.

Kidani A, Izumi H, Yoshida Y, Kashiwagi E, Ohmori H, Tanaka T, Kuwano M, Kohno K.

Int J Oncol. 2009 Dec;35(6):1435-40.

PMID:
19885567
13.

Multicenter safety study of mFOLFOX6 for unresectable advanced/recurrent colorectal cancer in elderly patients.

Sugimoto S, Katano K, Kanazawa A, Yoshimura H, Kidani A, Takeda H, Makino M, Ozaki N, Tanaka T, Ikeguchi M.

J Exp Clin Cancer Res. 2009 Aug 7;28:109. doi: 10.1186/1756-9966-28-109.

14.

Programmed cell death protein 4 down-regulates Y-box binding protein-1 expression via a direct interaction with Twist1 to suppress cancer cell growth.

Shiota M, Izumi H, Tanimoto A, Takahashi M, Miyamoto N, Kashiwagi E, Kidani A, Hirano G, Masubuchi D, Fukunaka Y, Yasuniwa Y, Naito S, Nishizawa S, Sasaguri Y, Kohno K.

Cancer Res. 2009 Apr 1;69(7):3148-56. doi: 10.1158/0008-5472.CAN-08-2334. Epub 2009 Mar 24.

15.

Ets regulates peroxiredoxin1 and 5 expressions through their interaction with the high-mobility group protein B1.

Shiota M, Izumi H, Miyamoto N, Onitsuka T, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Ono M, Kuwano M, Naito S, Sasaguri Y, Kohno K.

Cancer Sci. 2008 Oct;99(10):1950-9. doi: 10.1111/j.1349-7006.2008.00912.x.

16.

Twist and p53 reciprocally regulate target genes via direct interaction.

Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, Hirano G, Takahashi M, Naito S, Kohno K.

Oncogene. 2008 Sep 18;27(42):5543-53. doi: 10.1038/onc.2008.176. Epub 2008 May 26.

PMID:
18504427
17.

Tip60 is regulated by circadian transcription factor clock and is involved in cisplatin resistance.

Miyamoto N, Izumi H, Noguchi T, Nakajima Y, Ohmiya Y, Shiota M, Kidani A, Tawara A, Kohno K.

J Biol Chem. 2008 Jun 27;283(26):18218-26. doi: 10.1074/jbc.M802332200. Epub 2008 May 5.

18.

Twist promotes tumor cell growth through YB-1 expression.

Shiota M, Izumi H, Onitsuka T, Miyamoto N, Kashiwagi E, Kidani A, Yokomizo A, Naito S, Kohno K.

Cancer Res. 2008 Jan 1;68(1):98-105. doi: 10.1158/0008-5472.CAN-07-2981.

Supplemental Content

Loading ...
Support Center